Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial

Gavin Giovannoni, Gilmore O’Neill, Krzysztof Selmaj et al.|The Lancet Neurology|2014

Cited by 94